Clark Financial Services Group Inc Obs Eva Sa Transaction History

Clark Financial Services Group Inc

  • $108 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$0.14 - $1.83 $140 - $1,830
-1,000 Reduced 8.7%
10,500 $1,000
Q1 2022

May 13, 2022
SELL
$1.1 - $2.17 $1,435 - $2,831
-1,305 Reduced 10.19%
11,500 $17,000
Q1 2021

May 17, 2021
BUY
$2.01 - $5.05 $2,623 - $6,590
1,305 Added 11.35%
12,805 $41,000
Q2 2020

Aug 12, 2022
BUY
$2.01 - $5.95 $23,114 - $68,425
11,500 New
11,500 $19,000

Others Institutions Holding OBSV

# of Institutions
2
Shares Held
88K
Call Options Held
0
Put Options Held
0
View Full List

About ObsEva SA

OBSV Quotes by TradingView
  • Ticker OBSV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,499,200
  • Description
  • ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...
More about OBSV
Track This Portfolio

Track Clark Financial Services Group Inc Portfolio

Follow Clark Financial Services Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clark Financial Services Group Inc , based on Form 13F filings with the SEC.

News

Stay updated on Clark Financial Services Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email